ResultsIntegrated Filing- Financial

AHCL's board approved Q2 & H1 FY26 standalone results.

Amrutanjan Health Care Limited logo
Amrutanjan Health Care LimitedAMRUTANJAN · Filed with the exchange

Revenue from operations for Q2 rose 7.1% YoY to ₹117.70 Cr.

Net profit surged 18.3% YoY to ₹13.96 Cr, with EPS at ₹4.83. For H1 FY26, revenue increased 9.4% to ₹211.75 Cr, and net profit jumped 35.7% to ₹22.27 Cr.

This strong profit growth was aided by total expenses growing slower than revenue, partly due to a slight dip in advertisement spending.

The board also announced a ₹1 per share interim dividend.

These results reflect strong financial momentum, driven by effective cost management and revenue growth.

Read the original filing(PDF)

No comments yet. Be the first.

More from Amrutanjan Health Care Limited

All announcements